It’s a ‘risky’ ventureByJustine Calma@justcalmaSep 15, 2021, 8:30am EDT
Share this story
- Share this on Facebook(opens in new window)
- Share this on Twitter(opens in new window)
- SHAREAll sharing options
/cdn.vox-cdn.com/uploads/chorus_image/image/69860833/ben_george.0.jpeg)
A flashy new biotech startuplaunchedyesterday called Colossal is on a mission to make an elephant-woolly mammoth mashup — with the ultimate goal of promoting biodiversity and combating climate change, it says. The effort has gotten a lot of hype and big-name backers, but scientists who work in conservation are still pretty skeptical.THE SCIENCE BEHIND COLOSSAL IS IN VERY EARLY STAGES AND IS MIRED IN ETHICAL QUANDARIES
The science behind Colossal is in very early stages and is mired in ethical quandaries. The company won’t actually bring back a woolly mammoth, which hasn’t roamed the Earth in about 10,000 years. Instead, Colossal’s de-extinction effort…
View original post 1,526 more words